AU1810899A - Neuropilins and use thereof in methods for diagnosis and prognosis of cancer - Google Patents

Neuropilins and use thereof in methods for diagnosis and prognosis of cancer

Info

Publication number
AU1810899A
AU1810899A AU18108/99A AU1810899A AU1810899A AU 1810899 A AU1810899 A AU 1810899A AU 18108/99 A AU18108/99 A AU 18108/99A AU 1810899 A AU1810899 A AU 1810899A AU 1810899 A AU1810899 A AU 1810899A
Authority
AU
Australia
Prior art keywords
neuropilins
prognosis
diagnosis
cancer
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18108/99A
Inventor
Michael Klagsbrun
Hua-Quan Miao
Shay Soker
Seiji Takashima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of AU1810899A publication Critical patent/AU1810899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU18108/99A 1997-12-09 1998-12-09 Neuropilins and use thereof in methods for diagnosis and prognosis of cancer Abandoned AU1810899A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6915597P 1997-12-09 1997-12-09
US60069155 1997-12-09
US6968797P 1997-12-12 1997-12-12
US60069687 1997-12-12
PCT/US1998/026127 WO1999030157A2 (en) 1997-12-09 1998-12-09 Neuropilins in methods for diagnosis and prognosis of cancer

Publications (1)

Publication Number Publication Date
AU1810899A true AU1810899A (en) 1999-06-28

Family

ID=26749747

Family Applications (2)

Application Number Title Priority Date Filing Date
AU19060/99A Abandoned AU1906099A (en) 1997-12-09 1998-12-09 Peptide antagonists of vascular endothelial growth factor
AU18108/99A Abandoned AU1810899A (en) 1997-12-09 1998-12-09 Neuropilins and use thereof in methods for diagnosis and prognosis of cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU19060/99A Abandoned AU1906099A (en) 1997-12-09 1998-12-09 Peptide antagonists of vascular endothelial growth factor

Country Status (5)

Country Link
EP (1) EP1037994A1 (en)
JP (2) JP4312955B2 (en)
AU (2) AU1906099A (en)
CA (1) CA2313390A1 (en)
WO (2) WO1999029861A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7423125B2 (en) 1995-08-01 2008-09-09 Vegenics Limited Antibodies to VEGF-C
US6635421B1 (en) * 1997-12-09 2003-10-21 Children's Medical Center Corporation Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
AU783683B2 (en) * 2000-01-18 2005-11-24 Vegenics Limited VEGF-D/VEGF-C/VEGF peptidomimetic inhibitor
DE60131146T2 (en) 2000-02-25 2008-03-06 Ludwig Institute For Cancer Research MATERIALS AND METHODS CONTAINING HYBRID VASCULAR ENDOTHELIC GROWTH FACTORS DNA AND PROTEINS AND SCREENING METHOD FOR MODULATORS
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
EP1289565B1 (en) 2000-06-02 2015-04-22 Bracco Suisse SA Compounds for targeting endothelial cells
CA2421251A1 (en) * 2000-09-05 2002-03-14 Karolinska Innovations Ab Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
GB0029015D0 (en) 2000-11-28 2001-01-10 Univ London Medical device
US7611711B2 (en) 2001-01-17 2009-11-03 Vegenics Limited VEGFR-3 inhibitor materials and methods
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
GB0207644D0 (en) * 2002-04-02 2002-05-15 Ark Therapeutics Ltd Peptides and their use
EP2284180B1 (en) 2003-03-03 2015-09-09 Dyax Corp. Uses of peptides that specifically bind HGF receptor (cMET)
RU2414924C2 (en) * 2005-08-12 2011-03-27 Ридженерон Фармасьютикалз, Инк. Method of treating diseases by vegf antagonists
ES2363758T3 (en) 2005-08-15 2011-08-16 Vegenics Pty Ltd MODIFIED VEGF AND PDGF WITH IMPROVED ANGIOGENIC PROPERTIES.
WO2007047955A2 (en) * 2005-10-21 2007-04-26 Bayer Healthcare Llc Methods for prediction and prognosis of cancer, and monitoring cancer therapy
UA96139C2 (en) 2005-11-08 2011-10-10 Дженентек, Інк. Anti-neuropilin-1 (nrp1) antibody
WO2011087066A1 (en) * 2010-01-14 2011-07-21 株式会社三和化学研究所 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability
CA2803792A1 (en) 2010-07-09 2012-01-12 Genentech, Inc. Anti-neuropilin antibodies and methods of use
CN113226367A (en) 2018-04-06 2021-08-06 Atyr 医药公司 Compositions and methods comprising anti-NRP 2 antibodies
JP2022551603A (en) 2019-10-03 2022-12-12 エータイアー ファーマ， インコーポレイテッド Compositions and methods comprising anti-NRP2 antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173991C (en) * 1992-11-13 2004-11-03 马克斯普朗克科学促进协会 Fik-1 as receiptor of growth factor of blood vessel inner-skin
US6020473A (en) * 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor

Also Published As

Publication number Publication date
WO1999030157A9 (en) 1999-10-21
JP2001526032A (en) 2001-12-18
WO1999030157A2 (en) 1999-06-17
EP1037994A1 (en) 2000-09-27
AU1906099A (en) 1999-06-28
JP2009148293A (en) 2009-07-09
CA2313390A1 (en) 1999-06-17
WO1999029861A1 (en) 1999-06-17
JP4312955B2 (en) 2009-08-12
WO1999030157A3 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
AU1810899A (en) Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
EP1090291A4 (en) Method for early diagnosis of, and determination of prognosis in, cancer
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU6492798A (en) Microscope slide system and method of use
AU1807300A (en) Detection of loss of heterozygosity in tumor and serum of melanoma patients
AU5155398A (en) Anti-ccr5 antibodies and methods of use therefor
AU6148898A (en) 2-substituted 7-haloindenes and methods for synthesizing
AU2160297A (en) Method for the production of activated marked tumor-specific t cells and use thereof in treatment of tumors
AU3182999A (en) Methods of diagnosis and triage using cell activation measures
AU3154297A (en) Materials and methods for detection of breast cancer
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
AU2387900A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2582195A (en) Method of detecting cancer involving fragments of cytokeratin 18 and corresponding antibodies
AU1132595A (en) Chromosome 18q loss and prognosis in colorectal cancer
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU3159499A (en) Antigen preparation and use
AU4003597A (en) Methods of diagnosing and treating cancer
EP0934427A4 (en) Rh blood group antigen compositions and methods of use
AU9301998A (en) Composition and methods using galectin-1
EP0965840A4 (en) Method for analyzing annexin v in urine and use thereof
AU4150999A (en) Method and kit for early diagnosis of cancer
AU1763097A (en) Detection of prostate-specific antigen in breast tumors and serum
EP0794174A3 (en) Labeled reagents for use in immunoassays and fluorescent compounds and complexes used therein
AU9018598A (en) Prognostic compositions for prostate cancer and methods of use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase